Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Have we reached a molecular era in myelodysplastic syndromes?

Hematology. American Society of Hematology. Education Program - 10 Dec 2021

Voso Maria Teresa, Gurnari Carmelo

Abstract excerpt

Myelodysplastic syndromes (MDS) are characterized by heterogeneous biological and clinical characteristics, leading to variable outcomes. The availability of sophisticated platforms of genome sequencing allowed the discovery of recurrently mutated genes, which have led to a new era in MDS. This is reflected by the 2016 update of the World Health Organization classification, in which the criteria to define MDS...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Disease Management
Share to Gene Frequency

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Germ-Line Mutation

Share to Hematopoietic Stem Cell Transplantation

Share to Mutation

Share to Myelodysplastic Syndromes

Share to Prognosis

Source

Open in PubMed Open full text

Identifiers

PMID: 34889424
DOI: 10.1182/hematology.2021000276
PMCID: PMC8791166

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Have we reached a molecular era in myelodysplastic syndromes?PMID 34889424Read ↗

The Molecular Pathology of Myelodysplastic Syndrome.Semantic proximity Read ↗

Myelodysplastic Syndrome Updated.Semantic proximity Read ↗

Myelodysplastic syndromes: Biological and therapeutic consequences of the evolving molecular aberrations landscape.Semantic proximity Read ↗

Update on cytogenetic and molecular changes in myelodysplastic syndromes.Semantic proximity Read ↗

Current diagnosis and treatment for myelodysplastc syndromes.Semantic proximity Read ↗

The spectrum of genetic mutations in myelodysplastic syndrome: Should we update prognostication?Semantic proximity Read ↗

The genetic basis of myelodysplasia and its clinical relevance.Semantic proximity Read ↗

The Genetics of Myelodysplastic Syndromes: Clinical Relevance.Semantic proximity Read ↗

Recent advances in understanding the molecular pathogenesis of myelodysplastic syndromes.Semantic proximity Read ↗

Integrating genetics and epigenetics in myelodysplastic syndromes: advances in pathogenesis and disease evolutionSemantic proximity Read ↗

New Insight Into the Biology, Risk Stratification, and Targeted Treatment of Myelodysplastic Syndromes.Semantic proximity Read ↗

Molecular landscape of myelodysplastic neoplasms in disease classification and prognostication.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.